Chinese Journal of Tissue Engineering Research

Previous Articles     Next Articles

let-7f effects on the proliferation of bone marrow mesenchymal stem cells

Li Ming-zhe, Gong Zhe, Wang Jing, Wang Yi-wen, Yao Yao-bing, Hou Xiao-can, Jiao Shu-jie, Teng Jun-fang, Jia Yan-jie
  

  1. Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
  • Received:2015-11-08 Online:2015-12-03 Published:2015-12-03
  • Contact: Jia Yan-jie, M.D., Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
  • About author:Li Ming-zhe, Master, Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China
  • Supported by:

    Bone Marrow; Mesenchymal Stem Cells; Interleukin-6; Cell Proliferation; Tissue Engineering
    Funding: the National Natural Science Foundation of China, No. 81071114, 81371385

Abstract:

BACKGROUND: There is no clear understanding about the effect of let-7f and interleukin-6 (IL-6) on the proliferation of bone marrow mesenchymal stem cells and their relationship.
OBJECTIVE: To explore the effects of expression levels of let-7f and IL-6 on the proliferation of bone 
marrow mesenchymal stem cells and their relationship.
METHODS: (1) LV-rno-let-7f-up and LV-rno-let-7f-down were constructed and transfected into bone marrow mesenchymal stem cells of Sprague-Dawley rats, respectively. Then, there were four groups in the study: transfection upregulation group transfected with LV-rno-let-7f-up), transfection inhibition group (transfected with LV-rno-let-7f-down), negative control group (transfected with FU-RNAi-NC-LV), and untransfected group. The expression level of let-7f in each group was detected by qRT-PCR. The proliferation ability of cells and expression levels of IL-6 when let-7f expression was at different levels were detected by MTT, flow cytometry and ELISA. The expression of Cyclin D1 at mRNA and protein levels was detected by qRT-PCR and western blot, respectively. (2) To predict the potential target gene of let-7f, the wild-type/mutant IL-6 3’UTR reporter gene vectors were constructed, and cotransfected with let-7f/let-7f inhibitor respectively into the 293T cells to measure the luciferase.
RESULTS AND CONCLUSION: Compared with the negative control group, the proliferative and cloning capacities of cells in the transfection upregulation group were higher; the number of cells was significantly decreased at G1 stage and increased at S stage, and the apoptotic cells were reduced in number (P < 0.05). However, the transfection inhibition group had opposite results. The expression level of IL-6 in the transfection upregulation group was lower than that in the untransfected group and negative control group (P < 0.05); while in the transfection inhibition group, the expression level of IL-6 was significantly increased (P < 0.05). The expression of Cyclin D1 at mRNA and protein levels was up-regulated in transfection upregulation group (P < 0.05) and down-regulated in the transfection inhibition group (P < 0.05), but there was no significant difference between the negative control group and untransfected group (P > 0.05). Luciferase activity of cells transfected with wide-type IL-6 3’UTR and let-7f was significantly reduced (P < 0.05). These findings indicate that up-regulation of let-7f can promote the proliferative and cloning capacities of bone marrow mesenchymal stem cells and reduce cell apoptosis, but downrelation of let-7f exhibits an inhibitory effect. Overexpression of IL-6 can suppress the proliferation of bone marrow mesenchymal stem cells, which is considered to be a target gene of let-7f, and let-7f may suppress the expression of IL-6 to promote the cell proliferation. 

 

CLC Number: